Arrowhead Pharmaceuticals, Inc.ARWRNASDAQ
Loading
Gross Profit Growth AcceleratingAccelerating
Percentile Rank100
3Y CAGR+567.6%
Studio
Year-over-Year Change

Year-over-year gross profit growth rate

3Y CAGR
+567.6%/yr
Annual compound
Percentile
P100
Near historical high
vs 3Y Ago
297.6x
Strong expansion
Streak
1 yr
Consecutive growthAccelerating
PeriodValue
202522584.31%
2024-98.52%
2023-1.03%
202275.89%
202157.16%
20200.00%
20190.00%
20180.00%
20170.00%
20160.00%